2023年大麻临床结果研究会议的记录
Amie J Goodin1,2,3, Phuong T Tran1, Sam McKee1,3
1Pharmaceutical Outcomes and Policy, University of Florida, Gainesville, FL, USA.
Medical cannabis and cannabinoids
|October 30, 2023
概括
大麻临床结果研究会议 (CCORC) 突出了医用大麻研究的关键问题. 讨论的重点是公共卫生影响,研究障碍和大麻.
科学领域:
- 医学大麻研究 医学大麻研究
- 临床大麻的结果
- 公共卫生 公共卫生
背景情况:
- 医学大麻临床成果研究联盟 (CCORC) 是一个多所大学的合作.
- 第三届CCORC年会于2023年5月以混合会议的形式举行,旨在促进各方利益相关者之间的合作.
- 该会议旨在促进有关医用大麻临床效应的最新研究.
研究的目的:
- 解决关于医用大麻和公共健康的相互矛盾证据解的需要.
- 找出解决临床大麻研究障碍的解决方案,特别是针对怀孕者等特殊人群.
- 分析有关大麻使用及其对心理健康结果的影响的数据.
主要方法:
- 会议包括科学会议,包括面对面和直播组件.
- 演讲和讨论侧重于大麻临床结果研究中的新兴主题.
- 在科学家,政策制定者,行业专业人士和临床医生之间促进了合作.
主要成果:
- 出现了三个主要主题:相互矛盾的公共卫生证据,特殊人群的研究障碍,以及大麻使用对心理健康的影响.
- 会议促进了在医用大麻研究中的关键问题上的知识交流和合作.
- 讨论了为推进临床大麻研究所面临的挑战和潜在解决方案.
结论:
- 解决研究障碍和澄清证据对于理解医用大麻的临床影响至关重要.
- 需要进一步的研究,特别是关于弱势群体和心理健康结果.
- 每年的CCORC是推动大麻临床结果研究领域发展的重要平台.
相关概念视频
Clinical Trials
6.8K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.8K
Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
Preclinical Development: Overview
4.5K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.5K
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
287
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
287
Drug Administration and Therapy Phases: Overview
486
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
486


